Antibiotic Prophylaxis for Endoscopic Ultrasound Guided Fine Needle Aspiration of Pancreatic Cystic Lesions
NCT02261896 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 226
Last updated 2019-04-12
Summary
The purpose of this study is to determine whether the use of antibiotic prophylaxis is appropriate when performing a pancreatic cyst fine needle aspiration guided by endoscopic ultrasonography.
Conditions
- Pancreatic Cystic Lesion
Interventions
- DRUG
-
Evaluate usefullness of antibiotic prophylaxis
- DRUG
-
Ciprofloxacine 400 mg intravenous one dose followed by ciprofloxacine oral each 12 hours (complete 3 days)
Sponsors & Collaborators
-
Spanish Clinical Research Network - SCReN
collaborator NETWORK -
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
lead OTHER
Principal Investigators
-
Carlos Guarner-Argente, MD, PhD · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2018-07-31
- Completion
- 2018-07-31
Countries
- Spain
Study Locations
More Related Trials
-
Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
NCT00449878 ·Status: COMPLETED ·Phase: PHASE3
-
Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
NCT00510484 ·Status: COMPLETED ·Phase: PHASE3
-
Steady-state Pharmacokinetics of Ceftazidime/Avibactam in Cystic Fibrosis
NCT02504827 ·Status: COMPLETED ·Phase: PHASE4
-
Registry and Fluid Banking of Pancreatic Cystic Lesions
NCT01769534 ·Status: TERMINATED
-
First Study of Oral Cysteamine in Cystic Fibrosis
NCT02212431 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pharmacokinetic and Pharmacodynamic Analysis of Ceftaroline in Children and Adolescents With Cystic Fibrosis
NCT03771313 ·Status: COMPLETED ·Phase: PHASE4
-
Patienthèque of Finisterian (South of Brittany) Children With Cystic Fibrosis in the Time of Precision Medicine
NCT04137133 ·Status: RECRUITING ·Phase: NA
-
Study to Evaluate the Safety of CB-280 in Patients With Cystic Fibrosis
NCT04279769 ·Status: COMPLETED ·Phase: PHASE1
-
Management of Incidentally Discovered Pancreatic Cysts
NCT00550108 ·Status: TERMINATED ·Phase: PHASE3
-
Open-Label Phase III Long-Term Safety Trial of Liprotamase
NCT00449904 ·Status: COMPLETED ·Phase: PHASE3
-
Dose Escalation Study of KB001 in Cystic Fibrosis Patients Infected With Pseudomonas Aeruginosa
NCT00638365 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Safety, Tolerability & Efficacy in Cystic Fibrosis Patients With Abnormal Glucose Tolerance
NCT02955888 ·Status: TERMINATED ·Phase: PHASE2
-
Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified
NCT02526004 ·Status: COMPLETED ·Phase: NA
-
Biodistribution of Neutrophile Proteases in the Sputum of Patients Affected by Cystic Fibrosis
NCT00750932 ·Status: COMPLETED
-
Study to Assess the Safety and PK of Oral and IV Xenleta in Adults With Cystic Fibrosis
NCT05225805 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess an Enteric Microgranule Formulation of Adrulipase in Patients With Cystic Fibrosis
NCT05719311 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, Pharmacokinetics, and Efficacy of JBT-101 (Lenabasum) in Cystic Fibrosis
NCT02465450 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic Fibrosis
NCT00645788 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants.
NCT07035990 ·Status: RECRUITING ·Phase: PHASE1
-
Imipenem/Cilastatin/Relebactam Pharmacokinetics, Safety, and Outcomes in Adults and Adolescents With Cystic Fibrosis
NCT05561764 ·Status: TERMINATED ·Phase: PHASE4
-
Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis
NCT01543620 ·Status: UNKNOWN
-
28 Day Repeat Dose in Cystic Fibrosis Patients
NCT00903201 ·Status: COMPLETED ·Phase: PHASE2
-
Monitoring Response to Orkambi in Cystic Fibrosis Lung Disease by Inhaled Xenon MRI
NCT02848560 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations
NCT03000348 ·Status: COMPLETED ·Phase: PHASE2
-
Droplet-digital PCR for the Detection of Circulating Cell-free DNA in Patients With Cystic Echinococcosis: an Exploratory Study
NCT05769790 ·Status: UNKNOWN ·Phase: NA